scholarly journals PIPENN: Protein Interface Prediction with an Ensemble of Neural Nets

2021 ◽  
Author(s):  
Bas Stringer ◽  
Hans De Ferrante ◽  
Sanne Abeln ◽  
Jaap Heringa ◽  
K. Anton A. Feenstra ◽  
...  

Motivation: Protein interactions play an essential role in many biological and cellular processes, such as protein—protein interaction (PPI) in signaling pathways, binding to DNA in transcription, and binding to small molecules in receptor activation or enzymatic activity. Experimental identification of protein binding interface residues is a time-consuming, costly, and challenging task. Several machine learning and other computational approaches exist which predict such interface residues. Here we explore if Deep Learning (DL) can be used effectively for this prediction task, and which learning strategies and architectures may be most efficient. We introduce seven DL architectures that are applied to eleven independent test sets, focused on the residues involved in PPI interfaces and in binding RNA/DNA and small molecule ligands. Results: We constructed a large data set dubbed BioDL, comprising protein-protein interaction data from the PDB and protein-ligand interactions (DNA, RNA and small molecules) from the BioLip database. Additionally, we reused our existing curated homo- and heteromeric PPI data sets. We performed several experiments to assess the impact of different data features, spatial forms, encoding schemes, network initializations, loss functions, regularization mechanisms, and activation functions on the performance of the predictors. Benchmarking the resulting DL models with an independent test set (ZK448) shows no single DL architecture performs best on all instances, but that an ensemble of DL architectures consistently achieves peak prediction performance. Our PIPENN's ensemble predictor outperforms current state-of-the-art sequence-based protein interface predictors on all interaction types, achieving AUCs of 0.718 (protein—protein), 0.823 (protein—nucleotide) and 0.842 (protein—small molecule) respectively. Availability: Source code and data sets at https://github.com/ibivu/

2021 ◽  
Author(s):  
Anusmrithi U Sharma ◽  
Shweta Sharma ◽  
Gandhimathi Arumugam ◽  
Archana Padmanabhan Nair ◽  
Srinivas Ambala ◽  
...  

HIV-1 causes diverse immunomodulatory responses in the host, including the down-regulation of co-stimulatory proteins CD80/86, mediated by HIV-1 protein Nef, blunting T-cell activation. Using a screening cascade of biochemical and cell-based assays, we identified potent small molecules representing three chemical scaffolds namely amino pyrimidine, phenoxy acetamide and bi-aryl heteroaryl carbamate which target the protein-protein interaction interface of CD80/86 and Nef with sub-micromolar potency. These molecules restore CD80/86 surface levels in HIV-1-Nef infected antigen presenting cells and T-cell activation. Nef-CD80 interface and small molecule binding sites were mapped by using computational docking and structural studies, followed by validation by mutational analysis. This analysis resulted in the identification of two key residues, K99 and R111, which were associated with down-modulation of CD80 surface levels by Nef and important for small molecule binding. Targeting these interacting residues disabled Nef-mediated down-modulation of CD80 surface levels, consequently restoring T-cell activation. Thus, we validate a new target, the Nef-CD80/86 protein-protein interaction interface, with a potential to develop new inhibitors to counteract the immunomodulatory consequences of HIV-1.


2013 ◽  
Vol 13 (9) ◽  
pp. 989-1001 ◽  
Author(s):  
Arnout Voet ◽  
Eleanor F. Banwell ◽  
Kamlesh K. Sahu ◽  
Jonathan G. Heddle ◽  
Kam Y. J. Zhang

2011 ◽  
Vol 16 (8) ◽  
pp. 869-877 ◽  
Author(s):  
Duncan I. Mackie ◽  
David L. Roman

In this study, the authors used AlphaScreen technology to develop a high-throughput screening method for interrogating small-molecule libraries for inhibitors of the Gαo–RGS17 interaction. RGS17 is implicated in the growth, proliferation, metastasis, and the migration of prostate and lung cancers. RGS17 is upregulated in lung and prostate tumors up to a 13-fold increase over patient-matched normal tissues. Studies show RGS17 knockdown inhibits colony formation and decreases tumorigenesis in nude mice. The screen in this study uses a measurement of the Gαo–RGS17 protein–protein interaction, with an excellent Z score exceeding 0.73, a signal-to-noise ratio >70, and a screening time of 1100 compounds per hour. The authors screened the NCI Diversity Set II and determined 35 initial hits, of which 16 were confirmed after screening against controls. The 16 compounds exhibited IC50 <10 µM in dose–response experiments. Four exhibited IC50 values <6 µM while inhibiting the Gαo–RGS17 interaction >50% when compared to a biotinylated glutathione-S-transferase control. This report describes the first high-throughput screen for RGS17 inhibitors, as well as a novel paradigm adaptable to many other RGS proteins, which are emerging as attractive drug targets for modulating G-protein-coupled receptor signaling.


2013 ◽  
Vol 5 (12) ◽  
pp. 1423-1435 ◽  
Author(s):  
Lucy D Smith ◽  
Robin J Leatherbarrow ◽  
Alan C Spivey

2016 ◽  
Vol 128 (19) ◽  
pp. 5807-5811 ◽  
Author(s):  
Dong-Kyu Kwak ◽  
Hongsik Chae ◽  
Mi-Kyung Lee ◽  
Ji-Hyang Ha ◽  
Gaurav Goyal ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document